Magnesium
Reviews rate the sleep evidence as low to very low certainty. A 2026 systematic review of 12 RCTs (Lopresti et al.) concluded that the evidence does not support magnesium as a routine treatment for insomnia, though it may modestly improve some subjective outcomes in some adults, and a 2021 meta-analysis of 3 trials in 151 older adults (Mah & Pitre) found sleep onset about 17 minutes faster than on placebo, with no significant change in total sleep time. Individual trials split: 250mg/day of elemental magnesium as bisglycinate lowered insomnia scores slightly more than placebo over 4 weeks in 155 adults with poor sleep (Schuster et al., 2025; effect size d=0.2), 500mg/day as magnesium oxide helped 46 older adults with insomnia (Abbasi et al., 2012), and 320mg/day as citrate did no better than placebo in 100 adults over 51 (Nielsen et al., 2010). The two L-threonate trials cited here were funded by companies that make or supply the ingredient. Our review graded the evidence for stress, mood and cognition as preliminary.
Evidence reviewed:
Mechanism of action
Magnesium is an essential mineral. Supplement doses should be compared as elemental magnesium, not as the weight of the salt: 414mg of magnesium oxide provides 250mg of elemental magnesium, and 1g of Magtein (magnesium L-threonate) about 75mg. Trials have used magnesium oxide, citrate, chloride, bisglycinate and L-threonate, and evidence from one form does not transfer to another; we found no human trial of magnesium taurate on sleep, mood, anxiety or cognition. Effects may depend on magnesium status: in one trial, people with lower dietary magnesium gained more (an exploratory finding), and trials rarely measure baseline status.
Clinical evidence summary
Reviews rate the sleep evidence as low to very low certainty. A 2026 systematic review of 12 RCTs (Lopresti et al.) concluded that the evidence does not support magnesium as a routine treatment for insomnia, though it may modestly improve some subjective outcomes in some adults, and a 2021 meta-analysis of 3 trials in 151 older adults (Mah & Pitre) found sleep onset about 17 minutes faster than on placebo, with no significant change in total sleep time. Individual trials split: 250mg/day of elemental magnesium as bisglycinate lowered insomnia scores slightly more than placebo over 4 weeks in 155 adults with poor sleep (Schuster et al., 2025; effect size d=0.2), 500mg/day as magnesium oxide helped 46 older adults with insomnia (Abbasi et al., 2012), and 320mg/day as citrate did no better than placebo in 100 adults over 51 (Nielsen et al., 2010). The two L-threonate trials cited here were funded by companies that make or supply the ingredient. Our review graded the evidence for stress, mood and cognition as preliminary.
Human effect matrix
Based on human clinical trials only. Animal and in-vitro data excluded.
| Effect | Evidence | Magnitude | Studies |
|---|---|---|---|
| Sleep Quality | mixed | Small | 7 |
| Memory & Cognition | preliminary | Small | 1 |
Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results
Documented benefits
- Slightly better insomnia scores with 250mg/day of elemental magnesium as bisglycinate (one 4-week RCT, small effect)
- Faster sleep onset in older adults with insomnia (a pooled analysis of 3 small trials, low-certainty evidence)
Side effects & cautions
- Diarrhoea and other GI upset are the main side effects and the basis of the 350mg/day upper limit for supplemental magnesium; a 2023 review of 10 studies (128–1,200mg/day) found no significant excess of diarrhoea in 7, and its authors argue the limit should be re-evaluated. In a 729mg/day trial, all participants had soft stools
- Reduced kidney function raises the risk of high blood magnesium (hypermagnesemia): in older patients prescribed magnesium oxide, creatinine clearance of 28.2mL/min or less was a significant risk factor. People with reduced kidney function should take supplemental magnesium only on medical advice
- L-threonate trials of 3–6 weeks reported no significant adverse reactions; long-term safety is not established
- This review did not search for drug interactions or for safety in pregnancy
How to take
Stacking recommendations
Ingredients that pair well with Magnesium and why.
Both were in a 3-day blend trial of 16 healthy adults (with glycine, tart cherry powder and L-theanine) that shortened sleep onset by 24 minutes (Langan-Evans 2023); the abstract gives no doses, so what each adds is unknown.
Both were in the same 3-day, 16-person blend trial (Langan-Evans 2023); we cite no trial of the pair alone.
L-theanine was also in that blend trial; we cite no trial of magnesium and L-theanine alone.
Frequently asked questions
Which form of magnesium has the best evidence for sleep?
Bisglycinate has one placebo-controlled sleep RCT: 250mg/day of elemental magnesium for 4 weeks gave a small benefit on insomnia scores. Magnesium oxide (500mg/day) helped older adults with insomnia in one trial, and citrate (320mg/day) did not beat placebo in another. The L-threonate trials we cite were funded by companies that make or supply it. We found no human trial of magnesium taurate. Evidence for one form does not transfer to another.
How do I compare a label with the trial doses?
Use elemental magnesium, not the weight of the compound: 414mg of magnesium oxide provides 250mg of elemental magnesium, and 1g of Magtein (L-threonate) about 75mg. The positive bisglycinate and oxide sleep trials used 250–500mg/day of elemental magnesium; apart from L-threonate (about 75–150mg elemental), the trials we cite used 250mg/day or more.
Do sleep blends that contain magnesium work?
Only one such blend trial was found: 16 healthy young adults took a mix of tryptophan, glycine, magnesium, tart cherry powder and L-theanine for 3 days, and fell asleep 24 minutes faster and slept 22 minutes longer than on placebo. The abstract gives no dose for any ingredient, and the design cannot show what magnesium contributed.
Is magnesium safe?
The main side effect is diarrhoea, which is what the 350mg/day upper limit for supplemental magnesium is based on. People with reduced kidney function are at risk of high blood magnesium and should take magnesium supplements only on medical advice. This review did not search for drug interactions or safety in pregnancy, so ask a pharmacist or doctor if either applies to you.
Magnesium in Japan
Products in Japan
None of the stacks we have audited are listed in our catalogue in Japan yet.
Consumer Affairs Agency (FFC)
Regulatory note
本ページは教育目的の編集コンテンツであり、医学的助言を構成するものではありません。日本国内で販売される機能性表示食品（FFC）および特定保健用食品（FOSHU）は、消費者庁への届出または許可を必要とします。届出のない輸入品については、日本の薬機法（旧薬事法）の下で疾病治療を示唆する表現は規制されます。サプリメントを開始する前に、必ず資格のある医療専門家にご相談ください。This page is editorial and not medical advice. Foods with Function Claims (FFC) and Foods for Specified Health Uses (FOSHU) sold in Japan require notification or approval from the Consumer Affairs Agency. Imported products without notification cannot make disease-treatment claims under the Pharmaceuticals and Medical Devices (PMD) Act. Consult a qualified healthcare professional before starting any supplement.
Sources (10)expand
- PMID 42661485Magnesium Supplementation for Sleep in Adults: A Systematic Review of Randomized Controlled Trials (2026)
- PMID 33865376Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis (2021)
- PMID 40918053Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial (2025)
- PMID 23853635The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial (2012)
- PMID 21199787Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep (2010)
- PMID 39252819Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial (2024)
- PMID 41601871The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial (2025)
- PMID 36094342Nutritional Modulation of Sleep Latency, Duration, and Efficiency: A Randomized, Repeated-Measures, Double-Blind Deception Study (2023)
- PMID 37487817Perspective: Call for Re-evaluation of the Tolerable Upper Intake Level for Magnesium Supplementation in Adults (2023)
- PMID 37897255A case-control study showing low creatinine clearance and high magnesium intake as risk factors for hypermagnesemia in older individuals (2023)